Pei Hui, PhD, MD

Pei Hui, PhD, MD
Pathology, Gynecologic Pathology, Molecular Genetic Pathology
Accepting new patients? Yes
Referrals required? MD to MD Consult
Patient type treated: Child; Adult; Adolescent; Geriatrics

Pei Hui, M.D., Ph.D. obtained his medical degree from Xi’an Jiaotong University (China) and PhD degree from SUNY. He received combined anatomic and clinical pathology residency training at Yale-New Haven Hospital, followed by Oncological Pathology Fellowship training at MSKCC. He has joined the pathology faculty at Yale since 2001. Dr. Hui is a board certified surgical pathologist with clinical specialty areas including gynecological pathology and molecular diagnostics. As director of Yale Gynecological Pathology Service, he leads a world-class diagnostic service of providing tissue evaluation of all types of ovarian, uterine and cervical cancers. Dr. Hui has particular clinical expertise in the diagnostic workup of gestational trophoblastic disease (GTD). He serves on the editorial boards of International Journal of Gynecological Pathology, Human Pathology, American Journal of Clinical Pathology and Journal of Clinical Pathology. He has produced over 160 publications and authored three pathology textbooks including Cytology and Surgical Pathology of Gynecologic Neoplasms, Gestational Trophoblastic Disease: Diagnostic and Molecular Genetic Pathology, and Atlas of Intraoperative Consultation of Gynecologic Pathology. He is the responsible author for the current WHO classification of gestational trophoblastic disease. Dr. Hui serves on the Board of Directors of The International Society of Gynecological Pathologists (ISGyP).

  • Professor of Pathology and of Obstetrics, Gynecology and Reproductive Sciences
  • Director, Gynecologic Pathology
  • Clinical Director, Molecular Diagnostics Laboratory
  • Director, Gynecologic and Breast Pathology Fellowship Program.

Clinical Trials

New treatments for many conditions are tested in clinical trials, which ultimately bring lifesaving new drugs and devices to the patients who need them most. By participating in a clinical trial, you may get access to the most advanced treatments for your condition, and help determine their benefits for future patients.